MRI-guided focused ultrasound subthalamotomy for treating Parkinson’s (HTG734)Product type:GuidanceProgramme:HealthTech guidancePublished: 18 December 2024
MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson’s (HTG733)Product type:GuidanceProgramme:HealthTech guidancePublished: 18 December 2024
Devices for remote monitoring of Parkinson’s disease (HTG657)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 25 January 2024Published: 25 January 2023
Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms (TA934)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 November 2023
Suspected neurological conditions: recognition and referral (NG127)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 1 May 2019
Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (TA605)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 October 2019
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor (HTG474)Product type:GuidanceProgramme:HealthTech guidancePublished: 20 June 2018
Parkinson’s disease in adults (NG71)Product type:GuidanceProgramme:NICE guidelinePublished: 19 July 2017